Oncology PracticeFlu vaccine did not protect children with acute leukemiaDecember 11, 2017Leukemia, Myelodysplasia, TransplantationAMLALL
Hematology TimesHealth Canada approves midostaurin for AMLDecember 6, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesDrug receives fast track designation for FLT3+ rel/ref AMLDecember 2, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology NewsLevofloxacin prophylaxis in AML reduces febrile neutropenia admissionsDecember 1, 2017AMLPatient & Survivor Care
Hematology TimesStudy reveals potential target for AML treatmentNovember 30, 2017Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesFDA grants drug orphan designation for AML, MDSNovember 30, 2017AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Hematology NewsResearchers identify potential gene target for AML drug developmentNovember 28, 2017AMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesStudy reveals predictor of early mortality in AMLNovember 28, 2017Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesMethod identifies effective treatments for leukemias, lymphomasNovember 22, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALLNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology NewsStart with fitness when deciding on treatment for elderly AML patientsNovember 20, 2017AMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesTeam discovers mechanism of resistance in AMLNovember 18, 2017Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesRigosertib produces better OS in MDS than tAMLNovember 16, 2017AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Hematology TimesGeneric azacitidine approved in CanadaNovember 16, 2017AnemiaLeukemia, Myelodysplasia, TransplantationPharmacyAMLMyelodysplastic Syndrome
Hematology NewsAML candidate drug back in the pipelineNovember 9, 2017AMLLeukemia, Myelodysplasia, Transplantation
